Christophe Van Steenkiste

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease

Sara Van de Veire, Ingeborg Stalmans, Femke Heindryckx et al. · Cell · 2010 · 252 citations · Full text

Ocular Disease, Eye Disease, Ophthalmology +7

Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture

Sven Francque, Wim Laleman, Len Verbeke et al. · Laboratory Investigation · 2012 · 132 citations · Full text

Angiopoietin‐2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease

Sander Lefere, Frederique Van de Velde, Anne Hoorens et al. · Hepatology · 2018 · 129 citations

Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models

Stéphanie Coulon, Vanessa Legry, Femke Heindryckx et al. · Hepatology · 2013 · 97 citations